Mednet Logo
HomeRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

Do you have experience using photobiomodulation (Low Level Laser Therapy) to prevent and/or treat patients with oral mucositis or other side effects from chemo and radiation?

2
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Harbin Clinic

Taylor et al., PMID 36474663 Is anyone using this routinely as per the cited article?

In a patient with very high risk prostate cancer opting for prostatectomy, when, if ever, do you recommend neoadjuvant ADT?

3
4 Answers

Mednet Member
Mednet Member
Medical Oncology · Duke University School of Medicine

I generally do not offer ADT with or without a potent ARSI prior to RP even in high risk disease. While small single arm studies have shown that a few such men can achieve a pathologic CR and that path CR/MRD is associated with better outcomes after RP, for most patients, this approach has no clear ...

How do you approach Spine SBRT to 2 separate noncontiguous vertebral bodies ?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Michigan Healthcare Professionals, PC

I would feel comfortable treating concurrently. But, sequentially is fine, too. The vertebral SBRT RCT allowed for 3 consecutive to be treated, so if non-contiguous, would use the same planning criteria.

Do you continue to obtain dedicated imaging of the spine after palliative radiation for epidural disease or cord compression?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Michigan Healthcare Professionals, PC

If palliative, I do not routinely get imaging after treatment. The best way to know if it has worked is if the symptoms stabilize or resolve. Imaging is reserved for when a patient has worsening or return of symptoms. If oligometastatic and treating to higher dose/ablating, would consider imaging af...

Would you alter radiation recommendations for a patient with locally advanced rectal cancer and a history of abdominopelvic lymphoma radiation 40 years ago?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Fox Chase Cancer Center

In the case of more recent RT, I would get the records in order to inform treatment recommendations. However, records are typically impossible to get in this situation. We have several options here. The first is the avoidance of radiation, as was recently reported in the PROSPECT study. (Schrag et a...

Would you offer post-operative radiation for a T2N0 rectal cancer with less than 12 lymph nodes found in the specimen after LAR?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Sunnybrook Health Sciences Centre

I would like to know further details of the pathology before making a recommendation regarding post-op RT: location of the tumor - low vs mid vs high rectum, resection margin status, LVSI, EMVI. All these factors can help make a predictive assessment regarding the risk of local recurrence. For mid-...

What definitive dose would you use to treat a recurrent basal cell carcinoma in the oral cavity?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Florida

I don’t recall seeing a BCC in the oral cavity. Lips? 66-70 Gy at 2 Gy per fraction.

What is your recommended radiation field in early stage vulvar cancer (T1a-b) with myelosuppression, inconclusive SLNBx, and persistent positive margins?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

Would favor vulva and bilateral groin (limit to medial groin to reduce marrow exposure of femoral region).

Would you have any concerns about giving pelvic radiation in someone with a previous history of receipt of HIPEC?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

I have done it a few times but important to know pelvic adhesions at the time of surgery to counsel better about the risk of SBO (pros vs. cons).

How would you manage a ER/PR positive, HER2-negative grade 2 T3N0 invasive breast cancer s/p adjuvant chemotherapy who had post-operative complications with reconstruction?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Allegheny Health Network, Pittsburgh

The role of PMRT for pathologic T3N0 cancers remains controversial. However, I would consider PMRT for a woman in her 30s with T3N0 disease with LVSI. In terms of delay, would depend on how long since surgery and if the patient was receiving chemotherapy during that time. Literature has used differe...